QL
CRL icon

Quarry LP’s Charles River Laboratories CRL Stock Holding History

Quarry LP’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36K Buy
+6
New +$1.07K ﹤0.01% 1843
2025
Q4 		– Sell
-125
Closed -$19.6K – 2225
2025
Q3 		$19.6K Buy
+125
New +$19.9K ﹤0.01% 1427

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Quarry LP's CRL Position: Q2 2026 in Review

Quarry LP opened a new position in Charles River Laboratories (CRL) in Q2 2026: 6 shares worth $1.36K. The stake represents ﹤0.01% of the portfolio and ranks #1843 among its holdings. This is a return to the name: Quarry LP previously reported a position in CRL as recently as Q3 2025.

Quarry LP first reported a position in CRL in Q3 2025 and has held it in 2 quarters since. The position peaked at $19.6K in Q3 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Quarry LP held 6 shares of Charles River Laboratories worth $1.36K as of Q2 2026.
  • Charles River Laboratories was a new Quarry LP position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1843 holding.
  • Quarry LP first reported a position in Charles River Laboratories in Q3 2025 and has held it in 2 quarters since.
  • Quarry LP's Charles River Laboratories position peaked at $19.6K in Q3 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.